№ files_lp_4_process_3_087943
This document provides supplementary materials from two Phase 2 clinical trials on the optimal dose of rifapentine for pulmonary tuberculosis, focusing on exposure-response relations and pharmacokinetic properties.
Year: 2021
Region / City: USA, Uganda, Vietnam
Topic: Pharmacokinetics of Rifapentine
Document Type: Supplementary Materials
Organization / Institution: Centers for Disease Control and Prevention, University of California San Francisco, University of Texas Health Science Center, and others
Authors: Radojka M. Savic, Marc Weiner, William Mac Kenzie, Melissa Engle, William C. Whitworth, John L. Johnson, Pheona Nsubuga, Payam Nahid, Nhung Viet Nguyen, Charles A. Peloquin, Kelly Dooley, Susan E. Dorman
Target Audience: Researchers, clinicians, health professionals
Date of Approval: Not provided
Date of Modifications: Not provided
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.